BioMaxima Statistics

Total Valuation

BioMaxima has a market cap or net worth of EUR 11.65 million. The enterprise value is 15.16 million.

Market Cap	11.65M
Enterprise Value	15.16M

Important Dates

The last earnings date was Friday, November 28, 2025.

Earnings Date	Nov 28, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	4.19M
Shares Outstanding	n/a
Shares Change (YoY)	-6.16%
Shares Change (QoQ)	+3.57%
Owned by Insiders (%)	22.38%
Owned by Institutions (%)	n/a
Float	2.69M

Valuation Ratios

The trailing PE ratio is 76.57.

PE Ratio	76.57
Forward PE	n/a
PS Ratio	0.84
PB Ratio	1.06
P/TBV Ratio	1.08
P/FCF Ratio	216.05
P/OCF Ratio	24.71
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 13.05, with an EV/FCF ratio of 281.19.

EV / Earnings	99.65
EV / Sales	1.08
EV / EBITDA	13.05
EV / EBIT	47.89
EV / FCF	281.19

Financial Position

The company has a current ratio of 1.41, with a Debt / Equity ratio of 0.34.

Current Ratio	1.41
Quick Ratio	0.71
Debt / Equity	0.34
Debt / EBITDA	3.25
Debt / FCF	69.43
Interest Coverage	1.20

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	2.32%
Revenue Per Employee	109,946
Profits Per Employee	1,207
Employee Count	126
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-35,622
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -4.94% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-4.94%
50-Day Moving Average	2.57
200-Day Moving Average	2.64
Relative Strength Index (RSI)	25.77
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BioMaxima had revenue of EUR 13.85 million and earned 152,096 in profits. Earnings per share was 0.04.

Revenue	13.85M
Gross Profit	6.55M
Operating Income	313,801
Pretax Income	116,474
Net Income	152,096
EBITDA	1.09M
EBIT	313,801
Earnings Per Share (EPS)	0.04

Full Income Statement

Balance Sheet

The company has 261,305 in cash and 3.74 million in debt, giving a net cash position of -3.48 million.

Cash & Cash Equivalents	261,305
Total Debt	3.74M
Net Cash	-3.48M
Net Cash Per Share	n/a
Equity (Book Value)	10.97M
Book Value Per Share	2.62
Working Capital	1.86M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 471,287 and capital expenditures -417,385, giving a free cash flow of 53,902.

Operating Cash Flow	471,287
Capital Expenditures	-417,385
Free Cash Flow	53,902
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 47.29%, with operating and profit margins of 2.27% and 1.10%.

Gross Margin	47.29%
Operating Margin	2.27%
Pretax Margin	0.84%
Profit Margin	1.10%
EBITDA Margin	7.84%
EBIT Margin	2.27%
FCF Margin	0.39%

Dividends & Yields

BioMaxima does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	6.16%
Shareholder Yield	6.16%
Earnings Yield	1.31%
FCF Yield	0.46%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BioMaxima has an Altman Z-Score of 2.64 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.64
Piotroski F-Score	4